The 2002 Value Creation Index: A Prescription for Pharmaceutical Health
The pharmaceutical industry is at a familiar crossroad: The forces that have rocked pharmaceutical companies over the past century are intensifying, and challenges from the new century are emerging at an equally intense pace. Companies are continuing to grapple with shorter periods of drug exclusivity, proliferation of generic competition, uncertain market growth for ethical products, and rising costs for research and development (R&D). At the … [ Read more ]
Content: Article | Source: Kearney | Subject: Industry Specific | Industry: Pharmaceutical